Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,46 USD | +1,28 % | -4,64 % | -15,84 % |
Resumen de negocios
Número de empleados: 99
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Therapeutics
100,0
%
| 51 | 100,0 % | 57 | 100,0 % | +11,84 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
99,6
%
| 51 | 99,6 % | 57 | 99,6 % | +11,89 % |
Europe
0,4
%
| 0 | 0,4 % | 0 | 0,4 % | +0,45 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 01/07/13 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 01/06/14 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/14 |
Richard Graham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rhonda Farnum
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/07/18 |
Aine Miller
PRN | Corporate Officer/Principal | 47 | - |
Stacy Pryce
PRN | Corporate Officer/Principal | - | - |
Brett Grimaud
LAW | General Counsel | 50 | 01/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 01/06/14 |
Eran Broshy
BRD | Director/Board Member | 65 | 02/06/14 |
Burt Malkiel
BRD | Director/Board Member | 90 | 01/10/13 |
Director/Board Member | 59 | 01/07/20 | |
Susannah Gray
BRD | Director/Board Member | 63 | 26/02/23 |
Rick Winningham
CEO | Chief Executive Officer | 64 | 01/07/13 |
Jim Kelly
BRD | Director/Board Member | 43 | 11/04/23 |
Donal O'Connor
BRD | Director/Board Member | 73 | 21/10/15 |
Laurie Alsup
BRD | Director/Board Member | 70 | 13/02/18 |
Jeremy Grant
BRD | Director/Board Member | 36 | 21/12 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 48 559 955 | 41 512 139 ( 85,49 %) | 0 | 85,49 % |
Información de la empresa
Theravance Biopharma, Inc.
901 Gateway Boulevard
94080, South San
+650 808 6000
http://www.theravance.comVentas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,84 % | 459 M | |
+25,46 % | 659 mil M | |
+26,53 % | 557 mil M | |
-4,86 % | 359 mil M | |
+16,44 % | 322 mil M | |
+8,34 % | 297 mil M | |
+6,26 % | 215 mil M | |
+7,22 % | 210 mil M | |
-5,93 % | 200 mil M | |
-8,79 % | 149 mil M |
- Bolsa de valores
- Acciones
- Acción TBPH
- Empresa Theravance Biopharma, Inc.